Metastatic Castrate-resistant Prostate Cancer

Explore clinical trials studying Metastatic Castrate-resistant Prostate Cancer. Study availability and eligibility vary by location and protocol.

5 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Metastatic Castrate-resistant Prostate Cancer trial results

Recruiting

NCT06702995

Conditions: Metastatic Castrate-resistant Prostate Cancer, mCRPC (Metastatic Castration-resistant Prostate Cancer)
Locations: Cancer Hosipital of Shandong First Medical University,440 Jiyan Road, Jinan City, Shandong Province Jinan, Shandong, China

270 Dongan Road, Shanghai Shanghai, Shanghai Municipality, China

Completed

NCT01818986

Conditions: MCRPC, Metastatic Castrate-resistant Prostate Cancer
Locations: University of Texas Southwestern Medical Center Dallas, Texas, United States

Completed

NCT02987829

Conditions: Adenocarcinoma, Adenocarcinoma, Prostate, Carcinoma, +4 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Honor Health Scottsdale, Arizona, United States

University of California at Los Angeles Santa Monica, California, United States

Memorial Sloan Kettering Cancer Center New York, United States

Completed

NCT02008058

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States

Oregon Health and Science University Portland, Oregon, United States

University of Washington Seattle, Washington, United States

Completed

NCT01540526

Conditions: Metastatic Castrate-resistant Prostate Cancer, Solid Malignancies
Locations: University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States